Molecule Details
| InChIKey | CXFHUKRXFUSTMU-CRPOQRNNSA-N |
|---|---|
| Compound Name | (1R,3S,6S,10R,12R)-N-[(1R,2S)-2-ethenyl-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-23-methoxy-6-(1-methylcyclohexyl)-5,8-dioxo-9,29-dioxa-4,7,19-triazahexacyclo[16.10.2.11,4.010,12.020,25.026,30]hentriaconta-18,20(25),21,23,26(30)-pentaene-3-carboxamide |
| Canonical SMILES | C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@]23CCc4c(c(nc5ccc(OC)cc45)CCCCC[C@@H]4C[C@H]4OC(=O)N[C@@H](C4(C)CCCCC4)C(=O)N1C2)O3)C(=O)NS(=O)(=O)C1(C)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 9.55 |
| Source | ChEMBL |
2D Structure
Activity Profile